262 related articles for article (PubMed ID: 31669202)
1. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.
Wang R; Feng W; Wang H; Wang L; Yang X; Yang F; Zhang Y; Liu X; Zhang D; Ren Q; Feng X; Zheng G
Cancer Lett; 2020 Jan; 469():151-161. PubMed ID: 31669202
[TBL] [Abstract][Full Text] [Related]
2. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
3. CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells.
Dürr C; Pfeifer D; Claus R; Schmitt-Graeff A; Gerlach UV; Graeser R; Krüger S; Gerbitz A; Negrin RS; Finke J; Zeiser R
Cancer Res; 2010 Dec; 70(24):10170-81. PubMed ID: 21159639
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
[TBL] [Abstract][Full Text] [Related]
5. Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.
Wells G; Kennedy PT; Dahal LN
Front Immunol; 2021; 12():651687. PubMed ID: 33777052
[No Abstract] [Full Text] [Related]
6. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
Han AR; Lee JY; Kim HJ; Min WS; Park G; Kim SH
Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
[TBL] [Abstract][Full Text] [Related]
7. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
[TBL] [Abstract][Full Text] [Related]
9. Defining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imaging.
Duarte D; Amarteifio S; Ang H; Kong IY; Ruivo N; Pruessner G; Hawkins ED; Lo Celso C
Immunol Cell Biol; 2019 Feb; 97(2):229-235. PubMed ID: 30422351
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Anti-Leukemic Effects through Induction of Immunomodulating Microenvironment by Blocking CXCR4 and PD-L1 in an AML Mouse Model.
Hwang HS; Han AR; Lee JY; Park GS; Min WS; Kim HJ
Immunol Invest; 2019 Jan; 48(1):96-105. PubMed ID: 30204524
[TBL] [Abstract][Full Text] [Related]
11. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.
Wan Y; Zhang C; Xu Y; Wang M; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang Y; Wang J
BMC Cancer; 2020 May; 20(1):472. PubMed ID: 32456622
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Wang H; Franco F; Ho PC
Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
[TBL] [Abstract][Full Text] [Related]
13. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target.
Hashemi V; Maleki LA; Esmaily M; Masjedi A; Ghalamfarsa G; Namdar A; Yousefi M; Yousefi B; Jadidi-Niaragh F
Int Immunopharmacol; 2020 Jan; 78():106087. PubMed ID: 31841758
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells and regulatory T cells share common immunoregulatory pathways-related microRNAs that are dysregulated by acute lymphoblastic leukemia and chemotherapy.
Labib Salem M; Zidan AA; Ezz El-Din El-Naggar R; Attia Saad M; El-Shanshory M; Bakry U; Zidan M
Hum Immunol; 2021 Jan; 82(1):36-45. PubMed ID: 33162185
[TBL] [Abstract][Full Text] [Related]
16. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
[TBL] [Abstract][Full Text] [Related]
17. CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4(+)Foxp3(+) T and IL-17(+)CD4(+) Th17 cells.
Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Eo SK
J Neuroinflammation; 2016 Jul; 13(1):223. PubMed ID: 27439902
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of NK cells from leukemic microenvironment in MLL-AF9 induced acute myeloid leukemia.
Yang F; Wang R; Feng W; Chen C; Yang X; Wang L; Hu Y; Ren Q; Zheng G
Mol Immunol; 2018 Jan; 93():68-78. PubMed ID: 29154208
[TBL] [Abstract][Full Text] [Related]
19. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.
Sander FE; Nilsson M; Rydström A; Aurelius J; Riise RE; Movitz C; Bernson E; Kiffin R; Ståhlberg A; Brune M; Foà R; Hellstrand K; Thorén FB; Martner A
Cancer Immunol Immunother; 2017 Nov; 66(11):1473-1484. PubMed ID: 28721449
[TBL] [Abstract][Full Text] [Related]
20. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C
Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]